Outset Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018
Net Income	-172.8	-162.96	-131.94	-79.32	-85.46	-73.08
Depreciation & Amortization	7.08	6.28	6.18	3.76	1.94	1.49
Share-Based Compensation	38.63	27.2	17.45	21.44	0.88	0.79
Other Operating Activities	-4.29	-16.26	-21.96	-44.89	12.35	1.06
Operating Cash Flow	-131.37	-145.73	-130.26	-99.02	-70.29	-46.44
Capital Expenditures	-3.44	-8.33	-3.11	-9.08	-3.29	-1.77
Change in Investments	86.47	-57.97	-139.4	13.02	77.59	-67.01
Investing Cash Flow	83.03	-66.3	-142.51	3.95	74.3	-68.78
Share Issuance / Repurchase	10.43	8.04	160.15	255.99	0.44	0.31
Debt Issued / Paid	33.23	64.86	0	-1.36	-0.01	-0.01
Other Financing Activities	-	-	-	131.05	-0.18	134.57
Financing Cash Flow	43.65	72.9	160.15	385.68	0.25	134.87
Net Cash Flow	-4.7	-139.13	-112.62	290.61	4.25	19.65
Free Cash Flow	-134.81	-154.05	-133.37	-108.09	-73.59	-48.21
Free Cash Flow Margin	-103.40%	-133.52%	-129.99%	-216.47%	-488.03%	-2401.99%
Free Cash Flow Per Share	-2.72	-3.20	-2.93	-6.61	-85.76	-66.49

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).